Corey Whittle

Corey Whittle has extensive experience in quality assurance and quality control roles. Most recently, they served as the Head of Quality at BiomeBank since June 2023. Prior to that, Corey was the Quality Assurance Manager at vivoPharm Pty Ltd from May 2022 to June 2023. Corey also worked at Jurlique, where they held various positions such as Quality Assurance Manager, Quality Control Manager, and QC Laboratory & Compliance Team Leader from July 2015 to May 2022. Corey started their career at Mayne Pharma in 2000, where they held positions including Production Supervisor, Validation Specialist, QC Support Chemist, and QC Analyst from 2000 to 2015. Corey also briefly worked as a QC Analyst at CMAX in 2000.

Corey Whittle's education history is as follows:

Corey Whittle completed a Diploma of Leadership and Management with a focus on High Performance Management from Leadership Management Australia in the years 2021-2022.

From 1997 to 2000, Corey Whittle attended Flinders University, earning a Bachelor of Technology in Forensic & Analytical Chemistry. The field of study for this degree was Forensic Science and Technology.

In 2013, Corey Whittle acquired a Cert IV in Competitive Manufacturing from the Ashley Institute of Australia. The field of study for this certification was Lean Manufacturing. The end year for this program is not specified.

Additionally, in 2012, Corey Whittle obtained a Cert IV in Frontline Management from the Australian Institute of Management. No specific field of study is provided for this certification, and the end year is not specified.

Corey Whittle has also obtained two additional certifications. In December 2022, Corey Whittle completed The Art of Internal Auditing 2022 from the National Association of Testing Authorities, Australia. Furthermore, in September 2022, Corey Whittle obtained the OECD Principles of the Good Laboratory Practice 2022 certification, also from the National Association of Testing Authorities, Australia.